NCT07053462: CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 90 planned
- Started
- 1 Jun 2025
- Primary completion
- 18 Dec 2027
- Arms
- CRISPR-Edited Donor Kidney Transplant
- Results
- None posted
- 1 Jun 2025: Trial started
- 8 Jul 2025: Trial registered